#MammotomeEMEA would like to thank everyone who visited us at #ECR2025. We hope you enjoyed discovering our innovative beast care solutions. If you are interested in further discussing how our solutions can streamline your biopsy workflow, please follow this link: https://ow.ly/NFm550ViZEX We would like to take this opportunity to thank our partner GE HealthCare System for their valuable support during the event.
关于我们
At Mammotome, our expertise and compassion for breast care makes us the indispensable partner to physicians, clinicians, and patients. Our global team is committed to developing and distributing breakthrough technologies in breast care. With over 25 years as a trusted leader, we boast a comprehensive range of products that create better outcomes in breast care and provide physicians, clinicians and patients with educational resources that guide their journey. Our drive for innovation is rivaled only by our compassion for the people we serve, from the clinicians and surgeons who demand consistently precise solutions, to the patients and families seeking peace of mind. Headquartered in Cincinnati, OH, the Mammotome brand is sold in over 50 different countries throughout the world. We firmly believe that our employees drive the company’s success, and strive to provide an environment that offers challenging, stimulating and financially rewarding opportunities. Our associates know that every moment matters when it comes to advancing breast care diagnostics and surgical solutions. As an employee of our organization, you will be consistently challenged to deliver your best, and we’re passionate about retaining, developing and recruiting highly qualified and diverse candidates. Mammotome is proud to be a part of Danaher. Danaher’s science and technology leadership puts solutions from Mammotome at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day. Check out the ‘Jobs’ tab and join our hardworking, high-performing team of talented drivers! Social media terms of use at: https://www.mammotome.com/social-media-guidelines/
- 网站
-
https://www.mammotome.com
Mammotome的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 501-1,000 人
- 总部
- Cincinnati，OH
- 类型
- 上市公司
- 领域
- MI、MRI、Stereotactic、Ultrasound、Biopsy和breastcancer
地点
-
主要
获取路线
300 E Business Way
Suite 500
US，OH，Cincinnati，45241
Mammotome员工
-
David Johnson
Consultant to startups and SME's focusing on management techniques, product development and validation, market research, customer targeting…
-
Jeremy Doke
-
Theresa Riddle
Quality Technician at Mammotome, a Division of Devicor Medical Products, Inc.
-
Jodi Hafemeister
MedTech Commercial Leader | P&L Owner | Market Development | Product Launch Excellence | Passionate Leader and People Developer
动态
-
Have confidence at every step of the ultrasound-guided breast biopsy procedure and beyond. Learn how you can improve efficiency in your biopsy suite ?? The Mammotome? Elite Tetherless Vacuum-Assisted Biopsy System: https://ow.ly/ca0Y50VhetW The HydroMARK? Plus Breast Biopsy Site Marker: https://ow.ly/VktE50VhetV #Mammotome #HydroMARKPlus #WingsThatCling #MammotomeElite
-
-
The LumiMARK? Biopsy Site Marker is now available in Canada! Featuring three distinct multi-faceted 3D shapes, the LumiMARK? marker delivers excellent ultrasound visibility from any angle* for quick confirmation of target tissue. Follow the link to learn more: https://ow.ly/ctrn50VfSSR #Mammotome #LumiMARK *LumiMARK? Device Tests: PCR-000340 System Design, PCR-000579 Summative Usability, ES-002647 Claims Assessment
-
Offering the original standout features of the Mammotome Revolve? Dual Vacuum-Assisted Breast Biopsy System, now optimized to increase efficiency and ease of use for you and your staff. Follow the link to see the Mammotome Revolve? system in action. Link: https://ow.ly/L80w50VbRnV #Mammotome #MammotomeRevolve #ItsTimeToEvolve Footnote: System refinements include simple and intuitive user interface, upgraded cart with tray that enables additional workspace with minimal footprint, and increased efficiency and ease of use for clinicians and staff.
-
Surgical excellence demands dependability in the operating room. Whether it’s for a sentinel lymph node biopsy or the excision of a lesion, the Neoprobe? GDS is the device you can count on for every patient. Find out why the Neoprobe? GDS has been leading the way in gamma detection for over 20 years.* Link: https://ow.ly/B4N350VaAKl *Data on file- FDA 510k #K971167 from 1997 based on historical sales data and market size.
-
We are excited to announce that we have entered an exclusive agreement with Sirius Medical to distribute the Sirius Pintuition? System across the United States and Germany! This collaboration brings together our extensive breast care expertise and Sirius Medical's innovative Surgical Marker Navigation technology. The Pintuition? System enhances surgical precision and efficiency, reinforcing our commitment to driving progress in breast cancer treatment by providing clinicians with state-of-the-art tools that facilitate optimal care for patients. Learn more about this exceptional partnership and the Pintuition? System: https://ow.ly/1HlC50V7BmJ #Mammotome #SiriusMedical #Pintuition
-
-
Gain valuable insights, refine your biopsy techniques, and experience hands-on learning with leading specialists at our exclusive workshops. #ECR2025. The session will include a presentation by Pathologist Prof. Andrea Vecchione, and a hands-on pathology session where you'll follow the steps of tissue processing from collection to diagnosis, a highlight for radiologists. Additionally, enjoy an interactive ultrasound interventional lab focused on lesion excision, led by Pathologists Dr. K. Kozielek (Poznan) and Dr. P. Belli (Rome). Limited spots are available—register today! Link: https://ow.ly/KTGh50V5qR4 We look forward to seeing you in Vienna!
-
-
Through its simple and intuitive interface, the Mammotome Revolve? Dual Vacuum-Assisted Breast Biopsy System reduces the number of steps needed in stereotactic or ultrasound-guided procedures. Watch this video to see for yourself how you can complete procedures in just minutes with the newly refined* Mammotome Revolve? system. Link to learn more: https://lnkd.in/gYaHCTqy #Mammotome #MammotomeRevolve #ItsTimeToEvolve *System refinements include simple and intuitive user interface, upgraded cart with tray that enables additional workspace with minimal footprint, and increased efficiency and ease of use for clinicians and staff.
-
Stop by and visit #MammotomeEMEA at booth #303 during ECR 2025! Explore how our innovative solutions for breast care diagnostics and lesion excision can enhance efficiency in your biopsy workflow. Also, connect with experts, discover our latest advancements, and join one of our hands-on workshops focusing on radiology and pathology. Follow the link to learn more and sign up today! Link: https://ow.ly/kIG050V3ncz #ECR2025 #Mammotome #BreastCare #RadiologyInnovation
-
-
Achieve more accurate breast biopsy diagnoses with the Mammotome? Elite Tetherless Vacuum-Assisted Biopsy System. A recent study demonstrated a 37% reduction in the false negative rate when using the 10G Mammotome? Elite Tetherless Vacuum-Assisted Biopsy System compared to a traditional 14G core needle in 1,462 patients who underwent ultrasound-guided breast biopsy followed by surgical excision.* Follow the link to learn how you can enhance diagnostic accuracy with the Mammotome? Elite biopsy system. Link: https://ow.ly/ERsV50UZolh #TheScienceOfVAB #MammotomeElite *Zhang, Y., et al. “The comparison of efficacy and safety evaluation of vacuum-assisted Mammotome? Elite 10G system and the traditional BARD 14G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial.” International Journal of Surgery 109:1180–1187, April 2023, https://ow.ly/hoLT50UZolg JS9.0000000000000257